Company Information
Industry News
02/11 .2025
Biominhai Collaborates with Dek Vaccines for 13-Valent PCV Technology Transfer and Drug Supply
04/27 .2025
BioKangtai Advances Oral Pentavalent Rotavirus Vaccine to Phase III Clinical Trial
04/03 .2025
BioKangtai: 20-Valent Pneumococcal Vaccine Enters Phase II Clinical Trial
BioKangtai and AstraZeneca Announce Strategic Partnership to Advance Global Vaccine Innovation
BioKangtai at VIF: Shaping the Future of Global Vaccine Cooperation
BioKangtai Reaches Vaccine Technology Transfer Cooperation Intent with Ethiopia
03/24 .2025
DCVMN CEO Visits BioMinhai: Paving the Way for Vaccine Collaboration
